Mechanism-based inhibitors of glycosidases: design and applications.
暂无分享,去创建一个
Martin D. Witte | Wouter W. Kallemeijn | Tom Wennekes | Johannes M. F. G. Aerts | M. Witte | T. Wennekes | J. Aerts | W. Kallemeijn
[1] G. Liang,et al. Multifunctional fluorescent probe for sequential detections of glutathione and caspase-3 in vitro and in cells. , 2013, Analytical chemistry.
[2] H. Overkleeft,et al. Tuning the leaving group in 2-deoxy-2-fluoroglucoside results in improved activity-based retaining β-glucosidase probes. , 2012, Chemical communications.
[3] G. Semenza,et al. Stereospecific ring opening of conduritol-B-epoxide by an active site asparatate residue of sucrase-isomaltase. , 1977, Biochimica et biophysica acta.
[4] S. Withers,et al. Detailed comparative analysis of the catalytic mechanisms of beta-N-acetylglucosaminidases from families 3 and 20 of glycoside hydrolases. , 2005, Biochemistry.
[5] R. Brady,et al. Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease , 2004, Journal of Inherited Metabolic Disease.
[6] P. Stahl,et al. Identification of the macrophage mannose receptor as a 175-kDa membrane protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. B. Kempton,et al. Unequivocal demonstration of the involvement of a glutamate residue as a nucleophile in the mechanism of a retaining glycosidase , 1990 .
[8] G. Legler. Untersuchungen zum Wirkungsmechanismus glykosidspaltender Enzyme, I. Darstellung und Eigenschaften spezifischer Inaktivatoren , 1966 .
[9] G. Piccialli,et al. Identification of the active site nucleophile in the thermostable beta-glycosidase from the archaeon Sulfolobus solfataricus expressed in Escherichia coli. , 1997, Biochemistry.
[10] M. Sinnott,et al. Kinetic Isotope Effect Study of Transition States for the Hydrolyses of .alpha.- and .beta.-Glucopyranosyl Fluorides , 1994 .
[11] G. Legler,et al. Active site‐directed inhibition of galactosidases by conduritol C epoxides (1,2‐anhydro‐EPI‐and NEO‐inositol , 1981, FEBS letters.
[12] Jian‐Qiang Fan. A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity. , 2003, Trends in pharmacological sciences.
[13] S. Withers,et al. Identification of Glu340 as the active-site nucleophile in human glucocerebrosidase by use of electrospray tandem mass spectrometry. , 1994, The Journal of biological chemistry.
[14] G. Davies,et al. Structure of the endoglucanase I from Fusarium oxysporum: native, cellobiose, and 3,4-epoxybutyl beta-D-cellobioside-inhibited forms, at 2.3 A resolution. , 1997, Biochemistry.
[15] C. Klein,et al. CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101. , 2011, Blood.
[16] Matthew S Macauley,et al. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. , 2012, Nature chemical biology.
[17] H. Mori,et al. A Catalytic Amino Acid and Primary Structure of Active Site in Aspergillus niger α-Glucosidase , 1997 .
[18] William S York,et al. Regulation of Glycan Structures in Animal Tissues , 2008, Journal of Biological Chemistry.
[19] J. Kuiper,et al. Correction of Liver Steatosis by a Hydrophobic Iminosugar Modulating Glycosphingolipids Metabolism , 2012, PloS one.
[20] E. Beutler,et al. Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Scheule,et al. Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C mice. , 2012, Molecular genetics and metabolism.
[22] Daniel E. Koshland,et al. STEREOCHEMISTRY AND THE MECHANISM OF ENZYMATIC REACTIONS , 1953 .
[23] S. Withers,et al. Trapping and characterization of the reaction intermediate in cyclodextrin glycosyltransferase by use of activated substrates and a mutant enzyme. , 1997, Biochemistry.
[24] E. Chargaff,et al. A reinvestigation of the cerebroside deposited in Gaucher's disease. , 1958, The Journal of biological chemistry.
[25] S. Sonnino,et al. Membrane domains and the "lipid raft" concept. , 2012, Current medicinal chemistry.
[26] S. Withers,et al. Identification of Glu-120 as the catalytic nucleophile in Streptomyces lividans endoglucanase celB. , 1998, The Biochemical journal.
[27] H. Sjöström,et al. Purification and characterisation of amphiphilic lactase/phlorizin hydrolase from human small intestine. , 1981, European journal of biochemistry.
[28] V. Tiwari,et al. Carbohydrate based potential chemotherapeutic agents: recent developments and their scope in future drug discovery. , 2012, Mini reviews in medicinal chemistry.
[29] Rosemarie E. Venier,et al. Miglustat as a therapeutic agent: prospects and caveats , 2012, Journal of Medical Genetics.
[30] N. Sharon,et al. Identification of aspartic acid 52 as the point of attachment of an affinity label in hen egg white lysozyme. , 1973, The Journal of biological chemistry.
[31] S. Withers,et al. Mechanism of action and identification of Asp242 as the catalytic nucleophile of Vibrio furnisii N-acetyl-beta-D-glucosaminidase using 2-acetamido-2-deoxy-5-fluoro-alpha-L-idopyranosyl fluoride. , 2000, Biochemistry.
[32] J. Sussman,et al. Characterization of gene-activated human acid-β-glucosidase: Crystal structure, glycan composition, and internalization into macrophages , 2009, Glycobiology.
[33] S. Brul,et al. Efficient routing of glucocerebrosidase to lysosomes requires complex oligosaccharide chain formation. , 1986, Biochemical and biophysical research communications.
[34] Z. Shuzheng,et al. Inactivation of α-glucosidase by the active-site-directed inhibitor, conduritol B epoxide , 1985 .
[35] Kevin Burgess,et al. BODIPY dyes and their derivatives: syntheses and spectroscopic properties. , 2007, Chemical reviews.
[36] Y. Hannun,et al. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. , 1989, The Journal of biological chemistry.
[37] K. Umezawa,et al. Production, isolation and structure determination of a novel beta-glucosidase inhibitor, cyclophellitol, from Phellinus sp. , 1990, The Journal of antibiotics.
[38] H. Overkleeft,et al. Glycosphingolipids--nature, function, and pharmacological modulation. , 2009, Angewandte Chemie.
[39] G. Semenza,et al. Partial amino acid sequences around the essential carboxylate in the active sites of the intestinal sucrase-isomaltase complex. , 1976, The Journal of biological chemistry.
[40] O. Wolfbeis,et al. Clickable fluorophores for biological labeling--with or without copper. , 2009, Organic & biomolecular chemistry.
[41] Ronald R. Breaker,et al. Kinetics of RNA Degradation by Specific Base Catalysis of Transesterification Involving the 2‘-Hydroxyl Group , 1999 .
[42] P. Stahl,et al. The structure and function of vertebrate mannose lectin-like proteins , 1988, Journal of Cell Science.
[43] M. Langeveld,et al. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice , 2009, Hepatology.
[44] N. Radin,et al. Glucocerebrosidase: reconstitution of activity from macromolecular components. , 1973, The Biochemical journal.
[45] J. Barranger,et al. Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolase. , 1990, European journal of biochemistry.
[46] Colleen N. Scott,et al. pH-dependent Si-fluorescein hypochlorous acid fluorescent probe: spirocycle ring-opening and excess hypochlorous acid-induced chlorination. , 2013, Journal of the American Chemical Society.
[47] Andrew G. Watts,et al. Trypanosoma cruzi trans-sialidase operates through a covalent sialyl-enzyme intermediate: tyrosine is the catalytic nucleophile. , 2003, Journal of the American Chemical Society.
[48] M. Nakata,et al. A family of cyclophellitol analogs: synthesis and evaluation. , 1993, The Journal of antibiotics.
[49] S. Withers,et al. Cyclophellitol: a naturally occurring mechanism-based inactivator of beta-glucosidases. , 1991, Biochemical and biophysical research communications.
[50] S. Withers,et al. Approaches to labeling and identification of active site residues in glycosidases , 1995, Protein science : a publication of the Protein Society.
[51] J. Alper. Turning Sweet on Cancer , 2003, Science.
[52] J. Lakowicz,et al. Fluorescence properties of rhodamine 800 in whole blood and plasma. , 2000, Analytical biochemistry.
[53] G. Semenza,et al. Location of the two catalytic sites in intestinal lactase-phlorizin hydrolase. Comparison with sucrase-isomaltase and with other glycosidases, the membrane anchor of lactase-phlorizin hydrolase. , 1992, The Journal of biological chemistry.
[54] R. Brady,et al. Isolation and characterization of glucocerebrosidase from human placental tissue. , 1973, The Journal of biological chemistry.
[55] R. Proia,et al. Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[56] S. Withers,et al. Substituted glycals as probes of glycosidase mechanisms. , 1996, Bioorganic & medicinal chemistry.
[57] R R Breaker,et al. Characterization of a DNA-cleaving deoxyribozyme. , 2001, Bioorganic & medicinal chemistry.
[58] R. Rogers,et al. Distribution of murine mannose receptor expression from early embryogenesis through to adulthood , 1998, Cell and Tissue Research.
[59] G. Legler,et al. Amino acid sequence at the active site of β-glucosidase a from bitter almonds , 1978 .
[60] N. White,et al. Pharmacokinetic Properties ofAnti‐Influenza Neuraminidase Inhibitors , 2013, Journal of clinical pharmacology.
[61] Kelley W. Moremen,et al. Vertebrate protein glycosylation: diversity, synthesis and function , 2012, Nature Reviews Molecular Cell Biology.
[62] V. Shepherd,et al. Isolation and characterization of a mannose-specific endocytosis receptor from human placenta. , 1987, The Journal of biological chemistry.
[63] B. Henrissat,et al. Serratia marcescens chitobiase is a retaining glycosidase utilizing substrate acetamido group participation. , 1997, The Biochemical journal.
[64] S. Withers,et al. Unequivocal Identification of Asp-214 as the Catalytic Nucleophile of Saccharomyces cerevisiae -Glucosidase Using 5-Fluoro Glycosyl Fluorides , 1996, The Journal of Biological Chemistry.
[65] R. Wolfenden,et al. Spontaneous Hydrolysis of Glycosides , 1998 .
[66] K. Umezawa,et al. Accumulation of tissue glucosylsphingosine in Gaucher-like mouse induced by the glucosylceramidase inhibitor cyclophellitol. , 1993, Archives of Biochemistry and Biophysics.
[67] D. Givol,et al. Efficient in vitro and in vivo expression of human glucocerebrosidase cDNA. , 1987, DNA.
[68] A. J. Bennet,et al. Mutagenesis of the conserved active-site tyrosine changes a retaining sialidase into an inverting sialidase. , 2003, Biochemistry.
[69] H. Overkleeft,et al. Irreversible inhibitors and activity-based probes as research tools in chemical glycobiology. , 2011, Organic & biomolecular chemistry.
[70] R. Molyneux,et al. Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application , 2000 .
[71] J. Barranger,et al. Characterization of glucocerebrosidase in peripheral blood cells and cultured blastoid cells. , 1988, Experimental cell research.
[72] S. Withers,et al. Identification of glutamic acid 78 as the active site nucleophile in Bacillus subtilis xylanase using electrospray tandem mass spectrometry. , 1994, Biochemistry.
[73] G. Legler. Labelling of the active centre of a beta-glucosidase. , 1968, Biochimica et biophysica acta.
[74] K. Handa,et al. Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells , 2013, Proceedings of the National Academy of Sciences.
[75] Brandi L. Cantarel,et al. The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics , 2008, Nucleic Acids Res..
[76] Hongyu Zhao,et al. Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage , 2010, Proceedings of the National Academy of Sciences.
[77] S. Withers,et al. NMR spectroscopic characterization of a beta-(1,4)-glycosidase along its reaction pathway: stabilization upon formation of the glycosyl-enzyme intermediate. , 2007, Biochemistry.
[78] G. Sinclair,et al. Generation of a conditional knockout of murine glucocerebrosidase: utility for the study of Gaucher disease. , 2007, Molecular genetics and metabolism.
[79] G. A. van der Marel,et al. Ultrasensitive in situ visualization of active glucocerebrosidase molecules. , 2010, Nature chemical biology.
[80] S. Withers,et al. Insights into transition state stabilization of the β-1,4-glycosidase Cex by covalent intermediate accumulation in active site mutants , 1998, Nature Structural Biology.
[81] J. M. Benito,et al. Pharmacological chaperone therapy for Gaucher disease: a patent review , 2011, Expert opinion on therapeutic patents.
[82] M. Bogyo,et al. Tagging and detection strategies for activity-based proteomics. , 2007, Current opinion in chemical biology.
[83] R. Desnick,et al. Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[84] K. Hofmann,et al. Iminobiotin affinity columns and their application to retrieval of streptavidin. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[85] B. Henrissat,et al. Identification of an essential glutamate residue in the active site of endoglucanase III from Trichoderma reesei , 1993, FEBS letters.
[86] Richard L. Pederson,et al. Enzyme-catalyzed aldol condensation for asymmetric synthesis of azasugars : synthesis, evaluation, and modeling of glycosidase inhibitors , 1991 .
[87] S. Withers,et al. Imaging of enzyme replacement therapy using PET , 2010, Proceedings of the National Academy of Sciences.
[88] G. Legler,et al. Identification of an essential carboxylate group at the active site of lacZ beta-galactosidase from Escherichia coli. , 1984, European journal of biochemistry.
[89] H. Braun. External yeast β-fructosidase. Affinity labeling of the active site , 1976 .
[90] A. Vasella,et al. Structural studies of the beta-glycosidase from Sulfolobus solfataricus in complex with covalently and noncovalently bound inhibitors. , 2004, Biochemistry.
[91] Andrew G. Watts,et al. Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase. , 2004, Structure.
[92] K. Nakao,et al. Molecular cloning and expression of a novel klotho-related protein , 2000, Journal of Molecular Medicine.
[93] B Henrissat,et al. A classification of glycosyl hydrolases based on amino acid sequence similarities. , 1991, The Biochemical journal.
[94] T. C. Bruice,et al. Glycoside hydrolysis. II. Intramolecular carboxyl and acetamido group catalysis in beta-glycoside hydrolysis. , 1968, Journal of the American Chemical Society.
[95] S. Withers,et al. 2-Deoxy-2-fluoroglucosides: a novel class of mechanism-based glucosidase inhibitors , 1987 .
[96] Spencer J. Williams,et al. Synthesis and Testing of Mechanism‐Based Protein‐Profiling Probes for Retaining Endo‐glycosidases , 2006, Chembiochem : a European journal of chemical biology.
[97] K. Tatsuta. Total synthesis and chemical design of useful glycosidase inhibitors , 1996 .
[98] R. Laine,et al. A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 x 10(12) structures for a reducing hexasaccharide: the Isomer Barrier to development of single-method saccharide sequencing or synthesis systems. , 1994, Glycobiology.
[99] Ivone Carvalho,et al. α- and β-Glucosidase inhibitors: chemical structure and biological activity , 2006 .
[100] S. Withers,et al. Mechanisms of enzymatic glycoside hydrolysis. , 1994, Current opinion in structural biology.
[101] H. Overkleeft,et al. Bioorthogonal chemistry: applications in activity-based protein profiling. , 2011, Accounts of chemical research.
[102] A. Pastuszyn,et al. Exolytic hydrolysis of toxic plant glucosides by guinea pig liver cytosolic beta-glucosidase. , 1992, The Journal of biological chemistry.
[103] T. Berg,et al. Extremely rapid endocytosis mediated by the mannose receptor of sinusoidal endothelial rat liver cells. , 1989, The Biochemical journal.
[104] R H Glew,et al. Enzyme loading of erythrocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[105] S. Withers,et al. Glu280 is the nucleophile in the active site of Clostridium thermocellum CelC, a family A endo-beta-1,4-glucanase. , 1993, The Journal of biological chemistry.
[106] S. Withers,et al. Design and Synthesis of 2‘-Deoxy-2‘-Fluorodisaccharides as Mechanism-Based Glycosidase Inhibitors That Exploit Aglycon Specificity , 1997 .
[107] S. Withers,et al. Identification of the catalytic nucleophile in Family 42 β‐galactosidases by intermediate trapping and peptide mapping: YesZ from Bacillus subtilis , 2007, FEBS letters.
[108] K. Umezawa,et al. Inhibition of Experimental Metastasis by an α-Glucosidase Inhibitor, 1,6-Epi-cyclophellitol , 1993 .
[109] L. Clarke,et al. Transgenic mice expressing human glucocerebrosidase variants: utility for the study of Gaucher disease. , 2013, Blood cells, molecules & diseases.
[110] W. Jencks,et al. Reactions of anionic nucleophiles with .alpha.-D-glucopyranosyl fluoride in aqueous solution through a concerted, ANDN (SN2) mechanism , 1991 .
[111] I. L. Arbeloa,et al. Molecular forms of rhodamine B , 1981 .
[112] H. Lieb. Cerebrosidspeicherung bei Splenomegalie, Typus Gaucher , 1924 .
[113] J. Rouvinen,et al. Inversion of the roles of the nucleophile and acid/base catalysts in the covalent binding of epoxyalkyl xyloside inhibitor to the catalytic glutamates of endo-1,4-beta-xylanase (XYNII): a molecular dynamics study. , 2000, Protein engineering.
[114] Carolyn R Bertozzi,et al. A chemical approach for identifying O-GlcNAc-modified proteins in cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[115] Jennifer A. Prescher,et al. Rapid detection, discovery, and identification of post‐translationally myristoylated proteins during apoptosis using a bio‐orthogonal azidomyristate analog , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[116] L. Dijkhuizen,et al. Crystallographic Studies of the Interaction of Cyclodextrin Glycosyltransferase from Bacillus circulans Strain 251 with Natural Substrates and Products (*) , 1995, The Journal of Biological Chemistry.
[117] N. Radin. Treatment of Gaucher disease with an enzyme inhibitor , 1996, Glycoconjugate Journal.
[118] G. Davies,et al. Mapping the conformational itinerary of β-glycosidases by X-ray crystallography , 2003 .
[119] R. Brady,et al. Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. , 1966, The Journal of clinical investigation.
[120] J. Barranger,et al. Glucocerebrosidase deficiency and lysosomal storage of glucocerebroside induced in cultured macrophages. , 1987, Experimental cell research.
[121] N. Leslie,et al. Enzyme therapy for Gaucher disease: the first 5 years. , 1998, Blood reviews.
[122] Carolyn R Bertozzi,et al. A strategy for functional proteomic analysis of glycosidase activity from cell lysates. , 2004, Angewandte Chemie.
[123] Ronald R. Breaker,et al. Catalytic DNA: in training and seeking employment , 1999, Nature Biotechnology.
[124] J. M. Aerts,et al. Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease. , 1993, Biochimica et biophysica acta.
[125] F. Kreuzer,et al. Difluorboryl‐Komplexe von Di‐ und Tripyrrylmethenen , 1968 .
[126] G. Legler. Glycoside hydrolases: mechanistic information from studies with reversible and irreversible inhibitors. , 1990, Advances in carbohydrate chemistry and biochemistry.
[127] M. Sinnott,et al. Catalytic mechanism of enzymic glycosyl transfer , 1990 .
[128] M. Langeveld,et al. Glycosphingolipids and insulin resistance. , 2009, Progress in lipid research.
[129] G. Davies,et al. Sorting the diverse: the sequence-based classifications of carbohydrate-active enzymes , 2008 .
[130] S. Withers,et al. NAG-thiazoline, An N-Acetyl-β-hexosaminidase Inhibitor That Implicates Acetamido Participation , 1996 .
[131] G. Legler. Untersuchungen zum Wirkungsmechanismus glykosidspaltender Enzyme, III. Markierung des aktiven Zentrums einer β-Glucosidase aus Aspergillus wentii mit [14C]Condurit-B-epoxid , 1968 .
[132] C. Hollak,et al. Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[133] A. Khorlin,et al. Specific irreversible inhibition of sweet-almond β-glucosidase by some β-glycopyranosylepoxyalkanes and β-d-glucopyranosyl isothiocyanate , 1976 .
[134] M. Ho. Identity of ‘acid’ β-glucosidase and glucocerebrosidase in human spleen , 1973 .
[135] Yoram Tekoah,et al. Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems , 2013, Bioscience reports.
[136] Guang Yang,et al. Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity. , 2011, Advances in experimental medicine and biology.
[137] Dedreia Tull,et al. Crystallographic observation of a covalent catalytic intermediate in a β-glycosidase , 1996, Nature Structural Biology.
[138] H. Overkleeft,et al. Activity‐Based Profiling of Retaining β‐Glucosidases: A Comparative Study , 2011, Chembiochem : a European journal of chemical biology.
[139] S. Withers,et al. Positioning the acid/base catalyst in a glycosidase: studies with Bacillus circulans xylanase. , 1997, Biochemistry.
[140] D. Brooks. Getting into the fold. , 2007, Nature chemical biology.
[141] K. Umezawa,et al. Inhibition of glucocerebrosidase and induction of neural abnormality by cyclophellitol in mice. , 1992, Archives of biochemistry and biophysics.
[142] E. Hehre. A fresh understanding of the stereochemical behavior of glycosylases: structural distinction of "inverting" (2-MCO-type) versus "retaining" (1-MCO-type) enzymes. , 1999, Advances in carbohydrate chemistry and biochemistry.
[143] W. Jencks,et al. Reactions of Anionic Nucleophiles with α-D-Glucopyranosyl Fluoride in Aqueous Solution Through a Concerted, ANDN (SN2) Mechanism. , 1992 .
[144] L. Cowart,et al. Sphingolipid metabolism and analysis in metabolic disease. , 2011, Advances in experimental medicine and biology.
[145] Ying Sun,et al. Comparative Therapeutic Effects of Velaglucerase Alfa and Imiglucerase in a Gaucher Disease Mouse Model , 2010, PloS one.
[146] R. Wolfenden,et al. Spontaneous Hydrolysis of Ionized Phosphate Monoesters and Diesters and the Proficiencies of Phosphatases and Phosphodiesterases as Catalysts , 1998 .
[147] N. Asano. Glycosidase inhibitors: update and perspectives on practical use. , 2003, Glycobiology.
[148] J. Moult,et al. The identification by x-ray crystallography of the site of attachment of an affinity label to hen egg-white lysozyme. , 1973, Journal of molecular biology.
[149] R. Brady,et al. THE METABOLISM OF GLUCOCEREBROSIDES. I. PURIFICATION AND PROPERTIES OF A GLUCOCEREBROSIDE-CLEAVING ENZYME FROM SPLEEN TISSUE. , 1965, The Journal of biological chemistry.
[150] A. Ballabio,et al. Lysosomal disorders: from storage to cellular damage. , 2009, Biochimica et biophysica acta.
[151] D. Witte,et al. Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease. , 2003, The American journal of pathology.
[152] Gary Lee,et al. Pharmacological chaperones as therapeutics for lysosomal storage diseases. , 2013, Journal of medicinal chemistry.
[153] R. Dwek,et al. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[154] C. Sweeley,et al. Glycosphingolipids of human KB cells grown in monolayer, suspension, and synchronized cultures. , 1975, The Journal of biological chemistry.
[155] Alfred H. Merrill,et al. Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics , 2011, Chemical reviews.
[156] A. Bielawska,et al. Role of Ceramide in Cellular Senescence (*) , 1995, The Journal of Biological Chemistry.
[157] K. Iwabuchi,et al. GM3-enriched Microdomain Involved in Cell Adhesion and Signal Transduction through Carbohydrate-Carbohydrate Interaction in Mouse Melanoma B16 Cells* , 1998, The Journal of Biological Chemistry.
[158] S. Tsuji,et al. Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase. , 1986, The Journal of biological chemistry.
[159] K. Umezawa,et al. Biological activities of cyclophellitol. , 1990, The Journal of antibiotics.
[160] R. Brady,et al. Cerebroside synthesis in Gaucher's disease. , 1960, The Journal of clinical investigation.
[161] M. Humphries,et al. Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[162] R. Brady,et al. Lysosomal Storage Diseases , 1986, The Lancet.
[163] H. Overkleeft,et al. Triple bioorthogonal ligation strategy for simultaneous labeling of multiple enzymatic activities. , 2012, Angewandte Chemie.
[164] Mario Maas,et al. Substrate reduction therapy of glycosphingolipid storage disorders , 2006, Journal of Inherited Metabolic Disease.
[165] R. Hammer,et al. Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility. , 2006, The Journal of clinical investigation.
[166] Y. Hannun,et al. Programmed cell death induced by ceramide. , 1993, Science.
[167] J. M. Aerts,et al. Inhibition of Glycosphingolipid Synthesis Induces a Profound Reduction of Plasma Cholesterol and Inhibits Atherosclerosis Development in APOE*3 Leiden and Low-Density Lipoprotein Receptor−/− Mice , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[168] Hongbin Yan,et al. The synthesis and crystal structure of unsubstituted 4,4-difluoro-4-bora-3a,4a-diaza- s -indacene (BODIPY) , 2009 .
[169] G. Semenza,et al. Affinity labeling of the active sites in the sucrase-isomaltase complex from small intestine. , 1974, The Journal of biological chemistry.
[170] J. M. Aerts,et al. Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts. , 1987, European journal of biochemistry.
[171] S. Withers,et al. Glu-537, not Glu-461, is the nucleophile in the active site of (lac Z) beta-galactosidase from Escherichia coli. , 1992, The Journal of biological chemistry.
[172] J. Norris,et al. Interdiction of sphingolipid metabolism to improve standard cancer therapies. , 2013, Advances in cancer research.
[173] U. Heinemann,et al. Molecular and active-site structure of a Bacillus 1,3-1,4-beta-glucanase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[174] E. Levy-Lahad,et al. Replacement therapy with imiglucerase for type 1 Gaucher's disease , 1995, The Lancet.
[175] S. Withers,et al. Fluorinated and deoxygenated substrates as probes of transition-state structure in glycogen phosphorylase. , 1989, Biochemistry.
[176] G. Davies,et al. Structural basis for cyclophellitol inhibition of a β-glucosidase , 2007 .
[177] S. Withers,et al. Nature's many mechanisms for the degradation of oligosaccharides. , 2004, Organic & biomolecular chemistry.
[178] P. Høj,et al. Identification of glutamic acid 105 at the active site of Bacillus amyloliquefaciens 1,3-1,4-beta-D-glucan 4-glucanohydrolase using epoxide-based inhibitors. , 1992, The Journal of biological chemistry.
[179] B. Oostra,et al. Human lysosomal alpha-glucosidase. Characterization of the catalytic site. , 1991, The Journal of biological chemistry.
[180] B. Ganem,et al. A potent new class of active-site-directed glycosidase inactivators , 1988 .
[181] Roger A. Laine,et al. Invited Commentary: A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 × 1012 structures for a reducing hexasaccharide: the Isomer Barrier to development of single-method saccharide sequencing or synthesis systems , 1994 .
[182] J. Dambrosia,et al. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. , 1991, The New England journal of medicine.
[183] T. Cox,et al. 3 Gaucher's disease: clinical features and natural history , 1997 .
[184] J. van Marle,et al. Identification of the Non-lysosomal Glucosylceramidase as β-Glucosidase 2* , 2007, Journal of Biological Chemistry.
[185] J. Kanfer,et al. The Gaucher mouse. , 1975, Biochemical and biophysical research communications.
[186] R. Spiro. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. , 2002, Glycobiology.
[187] Eoin Fahy,et al. Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] , 2010, Journal of Lipid Research.
[188] B. Torbett,et al. A Chimeric Mouse Model of Gaucher Disease , 2002, Molecular medicine.
[189] S. Withers,et al. Breakdown of oligosaccharides by the process of elimination. , 2006, Current opinion in chemical biology.
[190] S. M. Van Patten,et al. Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease. , 2007, Glycobiology.
[191] H. Mori,et al. Chemical Modification and Amino Acid Sequence of Active Site in Sugar Beet α-Glucosidase , 1995 .
[192] A. Clarke,et al. Affinity labelling of Schizophyllum commune cellulase with [1-3H]-4,5-epoxypentyl β-cellobioside: synthesis of inhibitor and stoichiometry of interaction , 1989 .
[193] J. M. Aerts,et al. Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease , 2011, PloS one.
[194] B Poole,et al. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[195] Z. Dauter,et al. Catalysis and specificity in enzymatic glycoside hydrolysis: a 2,5B conformation for the glycosyl-enzyme intermediate revealed by the structure of the Bacillus agaradhaerens family 11 xylanase. , 1999, Chemistry & biology.
[196] A. K. Miller,et al. Biotin-binding by parenterally-administered streptavidin or avidin. , 1964, Biochemical and biophysical research communications.
[197] S. Morad,et al. Ceramide-orchestrated signalling in cancer cells , 2012, Nature Reviews Cancer.
[198] K. Sandhoff,et al. LYSOSOMES AS STOMACHS OF THE CELL PROVIDE CELLS WITH NUTRIENTS , 2011 .
[199] S. Withers,et al. The synthesis, testing and use of 5-fluoro-α-d-galactosyl fluoride to trap an intermediate on green coffee bean α-galactosidase and identify the catalytic nucleophile , 2000 .
[200] S. Withers,et al. Structural and Biochemical Characterization of Glycoside Hydrolase Family 79 β-Glucuronidase from Acidobacterium capsulatum , 2012, The Journal of Biological Chemistry.
[201] G. Semenza,et al. Tryptic digestion of native small-intestinal sucrase - isomaltase complex: isolation of the sucrase subunit. , 1975, European journal of biochemistry.
[202] L. Morales. Gaucher's Disease: A Review , 1996, The Annals of pharmacotherapy.
[203] M. Schwake,et al. Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis , 2014, Journal of Lipid Research.
[204] D. Vocadlo,et al. Synthesis and use of mechanism-based protein-profiling probes for retaining beta-D-glucosaminidases facilitate identification of Pseudomonas aeruginosa NagZ. , 2008, Journal of the American Chemical Society.
[205] P. Vogel,et al. Glycosidase inhibitors as potential HIV entry inhibitors? , 2004, Current drug metabolism.
[206] R. Brady,et al. Enhanced macrophage uptake of synthetically glycosylated human placental beta-glucocerebrosidase. , 1982, The Journal of biological chemistry.
[207] Lopatin De,et al. Fluorescein. Hapten and antibody active-site probe , 1971 .
[208] Huimin Ma,et al. Spectroscopic probes with changeable π-conjugated systems. , 2012, Chemical communications.
[209] F. Kiechle,et al. Glycosphingolipids in Health and Disease , 2004 .
[210] G. Legler. Untersuchungen zum Wirkungsmechanismus glykosidspaltender Enzyme, V. Markierung des aktiven Zentrums der β-Glucosidasen A und B aus dem Süßmandel-Emulsin mit [3H]6-Brom-6-desoxy-condurit-B-epoxid , 1970 .
[211] E. Galun,et al. A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme—A Preclinical and Phase I Investigation , 2009, PloS one.
[212] N. Sharon,et al. Chemical conversion of aspartic acid 52, a catalytic residue in hen egg-white lysozyme, to homoserine. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[213] Ben Zhong Tang,et al. The smallest and one of the brightest. Efficient preparation and optical description of the parent borondipyrromethene system. , 2009, The Journal of organic chemistry.
[214] K. Schray,et al. Active-site-directed inactivation of human liver α-l-fucosidase by conduritol C trans-epoxide , 1986 .
[215] S. Withers,et al. Identification of a covalent .alpha.-D-glucopyranosyl enzyme intermediate formed on a .beta.-glucosidase , 1988 .
[216] G. Legler,et al. Role of sugar hydroxyl groups in glycoside hydrolysis. Cleavage mechanism of deoxyglucosides and related substrates by beta-glucosidase A3 from Aspergillus wentii. , 1981, Biochimica et biophysica acta.
[217] S. Withers,et al. Crystallographic Evidence for Substrate-assisted Catalysis in a Bacterial β-Hexosaminidase* , 2001, The Journal of Biological Chemistry.
[218] B. Henrissat,et al. Mechanism-based inhibition and stereochemistry of glucosinolate hydrolysis by myrosinase. , 1996, Biochemistry.
[219] E. Bause,et al. Epoxyalkyl oligo-(1→4)-β-D-glucosides as active-site-directed inhibitors of cellulases , 1973 .
[220] S. Withers,et al. Mutagenesis of glycosidases. , 1999, Annual review of biochemistry.
[221] B. Henrissat,et al. Recent structural insights into the expanding world of carbohydrate-active enzymes. , 2005, Current opinion in structural biology.
[222] Matthew S Macauley,et al. O-GlcNAcase Uses Substrate-assisted Catalysis , 2005, Journal of Biological Chemistry.
[223] D. G. Naumoff. Hierarchical classification of glycoside hydrolases , 2011, Biochemistry (Moscow).
[224] S. Karlsson,et al. Murine models of acute neuronopathic Gaucher disease , 2007, Proceedings of the National Academy of Sciences.
[225] R. Proia,et al. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage. , 2002, The Journal of clinical investigation.
[226] P. Høj,et al. Active site-directed inhibition by optically pure epoxyalkyl cellobiosides reveals differences in active site geometry of two 1,3-1,4-beta-D-glucan 4-glucanohydrolases. The importance of epoxide stereochemistry for enzyme inactivation. , 1991, The Journal of biological chemistry.
[227] D. Kabelitz,et al. Ceramide: does it matter for T cells? , 2002, Trends in immunology.
[228] J. B. Kempton,et al. Inactivation of a beta-glucosidase through the accumulation of a stable 2-deoxy-2-fluoro-alpha-D-glucopyranosyl-enzyme intermediate: a detailed investigation. , 1992, Biochemistry.
[229] G. A. van der Marel,et al. Novel activity-based probes for broad-spectrum profiling of retaining β-exoglucosidases in situ and in vivo. , 2012, Angewandte Chemie.
[230] R. Brady,et al. Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease. , 1974, The New England journal of medicine.
[231] B. Henrissat,et al. Stereochemistry of Chitin Hydrolysis by a Plant Chitinase/Lysozyme and X-ray Structure of a Complex with Allosamidin , 2001 .
[232] E. Ginns,et al. Glucocerebrosidase, a lysosomal enzyme that does not undergo oligosaccharide phosphorylation. , 1988, Biochimica et biophysica acta.
[233] E. Ginns,et al. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene , 1992, Nature.
[234] Richard D. Cummings,et al. The repertoire of glycan determinants in the human glycome. , 2009, Molecular bioSystems.
[235] Gregor Jung,et al. Synthesis of the Core Compound of the BODIPY Dye Class: 4,4′-Difluoro-4-bora-(3a,4a)-diaza-s-indacene , 2009, Journal of Fluorescence.
[236] R. Brady,et al. METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE. , 1965, Biochemical and biophysical research communications.
[237] Brady Ro,et al. Investigations in enzyme replacement therapy in lipid storage diseases. , 1975 .
[238] S. Withers,et al. Mechanistic and Structural Analysis of a Family 31 α-Glycosidase and Its Glycosyl-enzyme Intermediate* , 2005, Journal of Biological Chemistry.
[239] E. Stang,et al. Endocytosis mediated by the mannose receptor in liver endothelial cells. An immunocytochemical study. , 1990, European journal of cell biology.
[240] R. Brady,et al. Investigations in enzyme replacement therapy in lipid storage diseases. , 1975, Federation proceedings.
[241] Bernard Henrissat,et al. High Resolution X-ray Crystallography Shows That Ascorbate Is a Cofactor for Myrosinase and Substitutes for the Function of the Catalytic Base* , 2000, The Journal of Biological Chemistry.
[242] J. Rouvinen,et al. Covalent binding of three epoxyalkyl xylosides to the active site of endo-1,4-xylanase II from Trichoderma reesei. , 1996, Biochemistry.
[243] S. Withers,et al. 2-Deoxy-2-fluoro-D-glycosyl fluorides. A new class of specific mechanism-based glycosidase inhibitors. , 1988, The Journal of biological chemistry.
[244] D. Witte,et al. Gaucher disease mouse models: point mutations at the acid β-glucosidase locus combined with low-level prosaposin expression lead to disease variants Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500202-JLR200 , 2005, Journal of Lipid Research.
[245] E. Hehre. Glycosyl transfer: a history of the concept's development and view of its major contributions to biochemistry. , 2001, Carbohydrate research.
[246] R. Glew,et al. The occurrence of beta-glucocerebrosidase activity in the glucocerebroside-rich deposits of Gaucher's disease. , 1974, Archives of biochemistry and biophysics.
[247] M. Okuyama,et al. Carboxyl group of residue Asp647 as possible proton donor in catalytic reaction of alpha-glucosidase from Schizosaccharomyces pombe. , 2001, European journal of biochemistry.
[248] S. Withers,et al. Identification of the Catalytic Nucleophile of the Family 29 α-L-Fucosidase from Thermotoga maritima through Trapping of a Covalent Glycosyl-Enzyme Intermediate and Mutagenesis* , 2003, Journal of Biological Chemistry.
[249] A Bairoch,et al. New families in the classification of glycosyl hydrolases based on amino acid sequence similarities. , 1993, The Biochemical journal.
[250] S. Withers,et al. Conduritol aziridine: a new mechanism-based glucosidase inactivator. , 1989, Biochemical and biophysical research communications.
[251] S. Withers,et al. Sugar ring distortion in the glycosyl-enzyme intermediate of a family G/11 xylanase. , 1999, Biochemistry.
[252] B. Agranoff,et al. Enzymic oxidation of cerebrosides: studies on Gaucher's disease. , 1962, Biochimica et biophysica acta.
[253] S. Withers,et al. Binding energy and catalysis. Fluorinated and deoxygenated glycosides as mechanistic probes of Escherichia coli (lacZ) beta-galactosidase. , 1992, The Biochemical journal.
[254] S. Withers,et al. Glycosidase mechanisms: anatomy of a finely tuned catalyst. , 1999, Accounts of chemical research.
[255] S. Withers,et al. Specificity Fingerprinting of Retaining β‐1,4‐Glycanases in the Cellulomonas fimi Secretome Using Two Fluorescent Mechanism‐Based Probes , 2007, Chembiochem : a European journal of chemical biology.